Almut Scherer
Boehringer Ingelheim (Switzerland)(CH)SCQM Foundation(CH)Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis, Autoimmune and Inflammatory Disorders Research, Systemic Lupus Erythematosus Research
Most-Cited Works
- → TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort(2017)256 cited
- → Tumor Necrosis Factor α Inhibition in Radiographic and Nonradiographic Axial Spondyloarthritis: Results From a Large Observational Cohort(2013)152 cited
- → Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study(2013)109 cited
- → Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry(2015)95 cited
- → Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis(2017)87 cited
- → Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study(2013)66 cited